The DOI matches its Crossref record; 32 of the 36 references it cites were found in a registry or an index.
Dual Targeting of HSC70 and HSP72 Inhibits HSP90 Function and Induces Tumor-Specific Apoptosis
Open accessAbstract
Heat-shock protein 70 (HSP70) isoforms contribute to tumorigenesis through their well-documented antiapoptotic activity and via their role as cochaperones for the HSP90 molecular chaperone. HSP70 expression is induced following treatment with HSP90 inhibitors, which may attenuate the cell death effects of this class of inhibitor. Here we show that silencing either heat-shock cognate 70 (HSC70) or HSP72 expression in human cancer cell lines has no effect on HSP90 activity or cell proliferation. However, simultaneously reducing the expression of both of these isoforms induces proteasome-dependent degradation of HSP90 client proteins, G1 cell-cycle arrest, and extensive tumor-specific apoptosis. Importantly, simultaneous silencing of HSP70 isoforms in nontumorigenic cell lines does not result in comparable growth arrest or induction of apoptosis, indicating a potential therapeutic window.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the latter of which may promote tumor resistance to therapy (23, 25)”
From FKBP51 Promotes Assembly of the Hsp90 Chaperone Complex and Regulates Androgen Receptor Signaling in Prostate Cancer Cells (2010) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,764
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M. F., Fritz, L. C., & Burrows, F. J. (2003) · Nature · doi:10.1038/nature01913 · Cited by 1,380
The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions
Daugaard, M., Rohde, M., & Jäättelä, M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.039 · Cited by 1,177
Pathways of chaperone-mediated protein folding in the cytosol
Young, J. C., Agashe, V. R., Siegers, K., & Hartl, F. U. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1492 · Cited by 1,121
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
Heat Shock Proteins 27 and 70: Anti-Apoptotic Proteins with Tumorigenic Properties
Garrido, C., Brunet, M., Mirjolet, C., Zermati, Y., Schmitt, E., & Kroemer, G. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3448 · Cited by 676
Drugging the Cancer Chaperone HSP90
Workman, P., Burrows, F. J., Neckers, L., & Rosen, N. X. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.012 · Cited by 531
Self-citationMolecular chaperones and the stress of oncogenesis
Mosser, D. D., & Morimoto, R. I. (2004) · Oncogene · doi:10.1038/sj.onc.1207529 · Cited by 512
Banerji, U., O’Donnell, A. E., Scurr, M. R., Pacey, S., Stapleton, S., Asad, Y. J., Simmons, L., Maloney, A., Raynaud, F. I., Campbell, M. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.612 · Cited by 490
Self-citation
Flagged first, then by citations
4 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 314
Walker, T. D., Mitchell, C., Park, M. A., Yacoub, A., Rahmani, M., Häussinger, D., Reinehr, R., Voelkel‐Johnson, C., Fisher, P. B., Grant, S., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1131 · Cited by 18
Zhou, Y., Cao, S., Li, H., Peng, X., Wang, Y., Fan, J., Wang, Y., Zhuang, S., Yu, X., & Mao, H. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.016 · Cited by 18
Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1
Lipinski, K. A., Britschgi, C., Schrader, K., Christinat, Y., Frischknecht, L., & Krek, W. (2016) · Oncotarget · doi:10.18632/oncotarget.8816 · Cited by 18
ErbB2 inhibition by lapatinib promotes degradation of mutant p53 protein in cancer cells
Li, D., & Marchenko, N. D. (2016) · Oncotarget · doi:10.18632/oncotarget.12878 · Cited by 18
Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas
Gaudio, E., Paduano, F., Ngankeu, A., Lovat, F., Fabbri, M., Sun, H., Gasparini, P., Efanov, A. A., Peng, Y., Zanesi, N. A. O., et al. (2012) · Blood · doi:10.1182/blood-2012-09-457374 · Cited by 18
Wang, D., Tan, K. S., Zeng, W., Li, S., Wang, Y., Xu, F., & Tan, W. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120336 · Cited by 17
Patwardhan, C. A., Kommalapati, V. K., Llbiyi, T., Singh, D., Alfa, E., Horuzsko, A., Körkaya, H., Panda, S. S., Reilly, C. A., Popik, V. V., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40933-9 · Cited by 17
Anti‐tumor activity of the HSP90 inhibitor SNX‐2112 in pediatric cancer cell lines
Chinn, D. C., Holland, W. S., Yoon, J. M., Zwerdling, T., & Mack, P. C. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23270 · Cited by 17
Hackl, C., Mori, A., Moser, C., Lang, S. A., Dayoub, R., Weiß, T. S., Schlitt, H. J., Geissler, E. K., Hellerbrand, C., & Stoeltzing, O. (2009) · Surgery · doi:10.1016/j.surg.2009.10.061 · Cited by 17
Das, B., & Kundu, C. N. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200721123046 · Cited by 16
Stühmer, T., Iskandarov, K., Gao, Z., Bumm, T. G. P., Grella, E., Jensen, M. R., Einsele, H., Chatterjee, M., & Bargou, R. C. (2012) · PubMed · Cited by 16
Darby, J. F., Vidler, L. R., Simpson, P. J., Al-Lazikani, B., Matthews, S. J., Sharp, S. Y., Pearl, L. H., Hoelder, S., & Workman, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-71969-w · Cited by 17
Self-citationWorkman, P., & Davies, F. E. (2011) · Oncotarget · doi:10.18632/oncotarget.266 · Cited by 15
Self-citationWendel, T., Zhen, Y., Suo, Z., Bruheim, S., & Więdłocha, A. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.12.017 · Cited by 14
Developing a genetic signature to predict drug response in ovarian cancer
Hyter, S. D., Hirst, J. J., Pathak, H. B., Pessetto, Z. Y., Koestler, D. C., Raghavan, R., Pei, D., & Godwin, A. K. (2017) · Oncotarget · doi:10.18632/oncotarget.23663 · Cited by 14
Gunaherath, G. M. K. B., Marron, M. T., Wijeratne, E. M. K., Whitesell, L. J., & Gunatilaka, A. A. L. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.06.042 · Cited by 14
Chen, Y., Chen, J., Yu, J., Yang, G., Temple, E., Harbinski, F., Gao, H., Wilson, C. J., Pagliarini, R. A., & Zhou, W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.574053 · Cited by 14
Zhao, Z., Zhu, J., Quan, H., Wang, G., Li, B., Zhu, W., Xie, C., & Lou, L. (2016) · Oncotarget · doi:10.18632/oncotarget.8818 · Cited by 14
Akhter, S., Chakraborty, S., Moutinho, D., Álvarez-Coiradas, E., Rosa, I., Viñuela, J. E., Domínguez, E., García, Á. G., & Requena, J. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185176 · Cited by 14
Heat Shock Factors in Protein Quality Control and Spermatogenesis
Nelson, V. K., Paul, S., Roychoudhury, S., Oyeyemi, I. T., Mandal, S. C., Kumar, N., Ravichandiran, V., & Pal, M. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-12966-7_11 · Cited by 13
Ghoshal, S., Rao, I. V., Earp, J. C., Jusko, W. J., & Wetzler, M. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1210-7 · Cited by 13
PKCι counteracts oxidative stress by regulating Hsc70 in an esophageal cancer cell line
Wang, B., Yang, Y., Yang, H., Liu, Y., Hao, J., Zhang, Y., Shi, Z., Jia, X., Zhan, Q., & Wang, M. (2012) · Cell Stress and Chaperones · doi:10.1007/s12192-012-0389-4 · Cited by 13
Meng, X., Wu, Q., Cao, C., Yang, W., Chu, S., Guo, H., Qi, S., & Bai, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06115-z · Cited by 12
Suppression of HSP70 Expression by Quercetin and Its Therapeutic Potential Against Cancer
Uçar, E. Ö., Şengelen, A., Mertoğlu, E., Pekmez, M., & Arda, N. (2018) · Heat shock proteins · doi:10.1007/978-3-319-89551-2_19 · Cited by 12
Growth-Regulated Hsp70 Phosphorylation Regulates Stress Responses and Prion Maintenance
Kao, C.-H., Ryu, S. W., Kim, M. J., Wen, X., Wimalarathne, O., & Paull, T. T. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00628-19 · Cited by 12
Chen, H., Zou, F., Wang, A., Miao, W., Liang, Q., Weisberg, E., Wang, Y., Liu, J. L., Wang, W., & Liu, Q. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00672-7 · Cited by 12
Kim, Y.-M., & Pyo, H. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1342 · Cited by 12
Design, synthesis and anticancer mechanistic studies of linked azoles
Islam, M. A., Zhang, Y., Wang, Y., & McAlpine, S. R. (2014) · MedChemComm · doi:10.1039/c4md00387j · Cited by 12
Novel Applications for an Established Antimalarial Drug: Tumoricidal Activity of Quinacrine
Yan, H., Bian, A., Gao, X., Li, H., Chen, Z., & Liu, X. (2018) · Future Oncology · doi:10.2217/fon-2017-0728 · Cited by 11
The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer
Eyermann, C. E., Haley, J. D., & Alexandrova, E. M. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03414-3 · Cited by 11
Failure to Guard: Mitochondrial Protein Quality Control in Cancer
Friedlander, J. E., Shen, N., Zeng, A., Korm, S., & Feng, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158306 · Cited by 11
Wang, H., Song, Y., Hao, D., Bai, M., Jin, L., Gu, J., Su, Y., Liu, L., Jia, C., & Du, L. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2388 · Cited by 11
A cell-based screen for inhibitors of protein folding and degradation
Boschelli, F., Golas, J. M., Petersen, R., Lau, V., Chen, L., Tkach, D., Zhao, Q., Fruhling, D. S., Liu, H., Nam, C.-E., et al. (2010) · Cell Stress and Chaperones · doi:10.1007/s12192-010-0200-3 · Cited by 11
Enriching protein-protein and functional interaction networks in human embryonic stem cells
-, M. (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000197 · Cited by 11
Exploiting autophagy in multiple myeloma
Ho, M., Patel, A. S., Hanley, C., Murphy, A., McSweeney, T., Zhang, L., McCann, A. H., O’Gorman, P., & Bianchi, G. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.25 · Cited by 11
Xu, X., Bao, Q., Jia, J.-M., Liu, F., Guo, X., Zhang, M.-Y., Wei, J., Lu, M., Xu, L., Zhang, X., et al. (2016) · Scientific Reports · doi:10.1038/srep19004 · Cited by 10
Welti, J., Bogdan, D., Figueiredo, I., Coleman, I., Vacas, J. J., Liodaki, K., Weigl, F., Buroni, L., Zeng, W.-T., Bernett, I., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-2386 · Cited by 7
Self-citationEvans, L. E., Jones, K., & Cheeseman, M. D. (2017) · Chemical Communications · doi:10.1039/c7cc01376k · Cited by 9
Hsp27 and Hsp70 Expression in Esophageal Squamous
Luz, C. C. F. [., Noguti, J., de Araújo, L. B., Mara, G., Gomes, T. S., & Ricardo, A. N. (2017) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2017.18.3.789 · Cited by 9
Reikvam, H., Brenner, A. K., Nepstad, I., Sulen, A., & Bruserud, Ø. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.924925 · Cited by 9
Sojka, D. R., Gogler‐Pigłowska, A., Klarzyńska, K., Klimczak, M., Żylicz, M., Głowala‐Kosińska, M., Krawczyk, Z., & Ścieglińska, D. (2020) · Cancers · doi:10.3390/cancers12102749 · Cited by 9
Zhang, R., Guo, X., Liang, C., Pei, J., Bao, P., Yin, M., Wu, F., Chu, M., & Yan, P. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00528 · Cited by 9
Inhibition of HSP90AA1 induces abnormalities in bovine oocyte maturation and embryonic development
Zhao, B., Li, H., Zhang, H., Lan, X., Ren, X., Zhang, L., Ma, H., Zhang, Y., & Wang, Y. (2024) · Reproduction · doi:10.1530/rep-23-0411 · Cited by 9
Discovery and Characterization of a Cryptic Secondary Binding Site in the Molecular Chaperone HSP70
O’Connor, S., Bihan, Y. L., Westwood, I. M., Liu, M., Mak, O. W., Zazeri, G., Povinelli, A. P. R., Jones, A. M., van Montfort, R., Reynisson, J., et al. (2022) · Molecules · doi:10.3390/molecules27030817 · Cited by 8
Leukocyte integrin α4β7 associates with heat shock protein 70
Chan, Y., Greenwood, D. R., Yang, Y., Leung, E. Y., & Krissansen, G. W. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2530-z · Cited by 8
Structure-based design of HSPA5 inhibitors: From peptide to small molecule inhibitors
Huang, M., Li, Z., Li, D., Walker, S., Greenan, C., & Kennedy, R. D. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.035 · Cited by 8
Chen, H., Li, L., & PAN, D. (2015) · Oncology Letters · doi:10.3892/ol.2015.3807 · Cited by 8
Ramapathiran, L., Bernaś, T., Walter, F., Williams, L. M., Düßmann, H., Concannon, C. G., & Prehn, J. H. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.137158 · Cited by 7
Wang, H., Song, Y., Bai, M., Jin, L., Gu, J., Su, Y., Liu, L., Jia, C., & Du, L. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.3.1285 · Cited by 7
Glucose-regulated protein 78 mediates the therapeutic efficacy of 17-DMAG in colon cancer cells
Chang, Y., Huang, C., Hung, C., Liu, H.-H., & Wei, P. (2015) · Tumor Biology · doi:10.1007/s13277-015-3076-0 · Cited by 6
Budina-Kolomets, A., Basu, S., Belcastro, L. T., & Murphy, M. E. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_10 · Cited by 6
Lee, S. L., Dempsey‐Hibbert, N., Vimalachandran, D., Wardle, T. D., Sutton, P. A., & Williams, J. H. H. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0774-0 · Cited by 6
Qiu, Q., Hu, B., He, X.-P., Luo, Q., Tang, G.-H., Long, Z., Chen, Z., & Xiu-sheng, H. (2012) · Genetics and Molecular Biology · doi:10.1590/s1415-47572012005000009 · Cited by 5
Exploiting Cancer Dependence on Molecular Chaperones
Sharp, S. Y., Jones, K., & Workman, P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00009-7 · Cited by 5
Self-citationInhibitor Combinations Reveal Wiring of the Proteostasis Network in Prostate Cancer Cells
Shkedi, A., Adkisson, M., Schroeder, A., Eckalbar, W. L., Kuo, S.-Y., Neckers, L. Μ., & Gestwicki, J. E. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01342 · Cited by 5
Targeting the C-Terminus of Hsp90 as a Cancer Therapy
McConnell, J. R., Wang, Y., & McAlpine, S. R. (2015) · Topics in medicinal chemistry · doi:10.1007/7355_2015_93 · Cited by 5
Heat shock protein 72 supports extracellular matrix production in metastatic mammary tumors
Lang, B. J., Holton, K. M., Guerrero-Gimenez, M. E., Okusha, Y., Magahis, P. T., Shi, A., Neguse, M., Venkatesh, S., Nhu, A. M., Gestwicki, J. E., et al. (2024) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2024.04.006 · Cited by 4
Sensitization of (colon) cancer cells to death receptor related therapies
Pintzas, A., Zhivotovsky, B., Workman, P., Clarke, P. A., Linardopoulos, S., Martinou, J., Lacal, J. C., Robine, S., Nasioulas, G., & Anděra, L. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.19600 · Cited by 4
Self-citationAn Unbiased Screen Identified the Hsp70-BAG3 Complex as a Regulator of Myosin-Binding Protein C3
Thompson, A. D., Wagner, M. J., Rodriguez, J., Malhotra, A., Roest, S. V., Lilienthal, U., Shao, H., Vignesh, M., Weber, K., Yob, J. M., et al. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2023.04.009 · Cited by 3
Specific radiation damage to halogenated inhibitors and ligands in protein–ligand crystal structures
Rodrigues, M. J., Cabry, M., Collie, G. W., Carter, M. W., McAndrew, C., Owen, R. L., Bellenie, B. R., Bihan, Y. L., & van Montfort, R. L. M. (2024) · Journal of Applied Crystallography · doi:10.1107/s1600576724010549 · Cited by 3
HSP90 Inhibitor-Based Strategies for Cancer Therapy: Advancing Toward Clinical Impact
Proia, D. A., & Bates, R. C. (2015) · Heat shock proteins · doi:10.1007/978-3-319-17211-8_15 · Cited by 3
New Indications for HSP90 and HSP70 Inhibitors as Antiviral Drugs
Howe, M. K., & Haystead, T. (2015) · Heat shock proteins · doi:10.1007/978-3-319-17211-8_10 · Cited by 3
Evaluating Dual Hsp90 and Hsp70 Inhibition as a Cancer Therapy
Buckton, L. K., Wang, Y., McConnell, J. R., & McAlpine, S. R. (2015) · Topics in medicinal chemistry · doi:10.1007/7355_2015_96 · Cited by 3
Hsp70 and Hsp27: Emerging Targets in Cancer Therapy
Rérole, A. L., Joly, A. L., Thuringer, D., & Garrido, C. (2009) · Springer eBooks · doi:10.1007/978-90-481-3415-1_9 · Cited by 3
Bridging structure and selectivity in chaperone‐mediated autophagy: towards targeted therapeutics
Sahu, D., Patel, I., Lakshman, K., Mapa, K., & Malhotra, N. (2025) · FEBS Journal · doi:10.1111/febs.70262 · Cited by 2
Allosteric Inhibitors of Hsp70: Drugging the Second Chaperone of Tumorigenesis
Srinivasan, S. R., Shao, H., Li, X., & Gestwicki, J. E. (2015) · Topics in medicinal chemistry · doi:10.1007/7355_2015_88 · Cited by 2
Sexual dimorphism of STGC3 tumor suppressor function in nasopharyngeal carcinoma CNE2 cells
Qiu, Q., Hu, B., Chen, Z. C., & He, X.-P. (2012) · Genetics and Molecular Research · doi:10.4238/2012.october.9.9 · Cited by 2
Molecular Chaperones and Ubiquitin Proteasome System in Tumor Biogenesis: An Overview
Ambasta, R. K. (2016) · Cell Biology & Cell Metabolism · doi:10.24966/cbcm-1943/100010 · Cited by 2
Therapeutic Implications of Heat Shock Proteins in Cancer
Shevtsov, M. A., & Multhoff, G. (2019) · Heat shock proteins · doi:10.1007/978-3-030-02254-9_11 · Cited by 2
Kadam, A. A., Abuthakir, M. H. S., Jubin, T., Vaishnav, J., Garg, A., Balaji, C., Suthar, D. H., & Begum, R. (2021) · Protein Expression and Purification · doi:10.1016/j.pep.2021.105923 · Cited by 2
Kataria, N., Kerr, B., Zaiter, S. S., McAlpine, S. R., & Cook, K. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/521989 · Cited by 2
HEAT SHOCK PROTEINS AS NOVEL CANCER THERAPEUTICS: TARGETING THE HALLMARKS OF CANCER
Li, C. (2011) · ProQuest Demo Repository · doi:10.25772/q1zf-3q75 · Cited by 2
Ncube, S. M., ArulJothi, K. N., Lang, D. M., Sinkala, M., Burmeister, C. A., Serala, K., Blackburn, J. M., & Prince, S. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-1031 · Cited by 1
Tall, J. R., Poele, R. T., Vasile, A. I., Ramagiri, P., Campbell, J., Davies, C. R., Powers, M. V., Roe, T., Sankaran, D., Wang, H., et al. (2026) · NAR Cancer · doi:10.1093/narcan/zcag008 · Cited by 1
Self-citationMolecular Chaperones and Co-chaperones as Therapeutic Targets for Cancer
Ahmad, A., & Muzaffar, M. (2016) · Journal of Molecular Pharmaceutics & Organic Process Research · doi:10.4172/2329-9053.1000e124 · Cited by 1
Heat Shock Proteins and Cancer
Öncel, M. (2012) · European Journal of Basic Medical Sciences · doi:10.21601/ejbms/9171 · Cited by 1
Large-scale crystallization and neutron crystallographic analysis of HSP70 in complex with ADP
Yokoyama, T., Ostermann, A., Schrader, T. E., & Mizuguchi, M. (2017) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x1701264x · Cited by 1
Role of HSP90 Inhibitors in the Treatment of Cancer
Coyne, G. O., Monge, C., & Chen, A. P. (2019) · Heat shock proteins · doi:10.1007/978-3-030-23158-3_6 · Cited by 1
HSP70 and FLT3-ITD: Targeting chaperone system to overcome drug resistance
Yang, J. C., & Weisberg, E. (2021) · Blood Science · doi:10.1097/bs9.0000000000000094 · Cited by 1
Vaccinia virus requires heat-shock proteins for genome replication and virion assembly
Mok, H. G. W. (2019) · UCL Discovery (University College London) · Cited by 1
Investigation of response and resistance to dasatinib in melanoma cell lines
Eustace, A. J. (2010) · Dublin City University Open Access Institutional Repository (Dublin City University) · Cited by 1
Ricart, K. C. (2010) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
MECHANISM-BASED STRATEGIES TO ENHANCE THE ACTIONS OF A
gomez, F. C. (2010) · Digital Commons-TMC (Texas Medical Center)
The Role of Hsp70 in Cancer: A Study of the Hsp70 / Akt Relationship
Koren, J. (2012) · Digital Commons - University of South Florida (University of South Florida)
The many roles of molecular chaperones and co-chaperones in tumour biology.
Ďurech, M., Vojtěšek, B., & Muller, P. (2012) · PubMed · Cited by 2
Exploiting the Dependency of Cancer Cells on Molecular Chaperones
Sharp, S. Y., Howes, J. E., & Workman, P. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849739689-00126
Self-citationPriming cardiovascular stem cells for transplantation using short-term hypoxia
Hernández, A. I. (2016) · CSUSB ScholarWorks (California State University, San Bernardino)
Munje, C. (2011) · CLOK (University of Central Lancashire)
Schwock, J. (2010) · TSpace (University of Toronto)
Identifying Molecular Chaperones as Therapeutic Targets for Cancer: A Mini Review
Ahmad, A., Farwell, M. A., & Muzaffar, M. (2017) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.1000224
Wei, Y. (2010) · UWSpace (University of Waterloo)
Law, E. W. P. (2016) · Figshare
Алдобаев, В. Н., Prezent, M. A., & Zavarzin, I. V. (2018) · Russian Chemical Bulletin · doi:10.1007/s11172-018-2339-5
Sheldon, J., & Lopez-Soto, E. J. (2009) · eCommons (Cornell University)
Maru, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-56024-1_10
Maru, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-1757-7_10
(2008) · Nature Chemical Biology · doi:10.1038/nchembio1008-589
Pérez-Ishiwara, D. G., Shibayama, M., Nakada‐Tsukui, K., Jeelani, G., Gómez-García, M. D. C., Medel-Flores, O., & Nozaki, T. (2022) · Microbiology Research Journal International · doi:10.9734/mrji/2022/v32i530390
Gao, Z., Zheng, J., Wu, X., Savinov, S., Zhao, C., & Xiao, H. (2024) · Food & Function · doi:10.1039/d4fo03211j
Zhang, R., & Lv, J. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s554080 · Cited by 1
Metadata
- Authors
- Powers, M. V., Clarke, P. A., & Workman, P.
- Affiliations
- Institute of Cancer Research (GB)
- Corresponding author
- Workman, Paul
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 14
- Issue
- 3
- Pages
- 250-262
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2170573493
- Cited by
- 307
- References
- 36
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 9 · 2021: 15 · 2020: 8 · 2019: 17 · 2018: 16 · 2017: 18 · 2016: 24 · 2015: 25 · 2014: 27 · 2013: 29 · 2012: 24
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research UK (C309/A8274, C309/A2187)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Hsc70, HSP72, HSP90, Hsp90 inhibitors, proteasomal degradation, Hsp90 client proteins, G1 cell cycle arrest, heat shock proteins, cancer cell lines, therapeutic window, anti-apoptotic effects
- MeSH terms
- Bortezomib, Boronic Acids, Cell Cycle, Cell Line, Humans, Kinetics, Neoplasms, Poly(ADP-ribose) Polymerases, Protease Inhibitors, Pyrazines, Transfection, Benzoquinones, Apoptosis, HSP70 Heat-Shock Proteins, HSP90 Heat-Shock Proteins, Proto-Oncogene Proteins c-raf, Protein Isoforms, RNA, Small Interfering, HCT116 Cells, Cell Line, Tumor, Proteasome Endopeptidase Complex, Lactams, Macrocyclic, Cell Proliferation, HSC70 Heat-Shock Proteins, HSP72 Heat-Shock Proteins, Cyclin-Dependent Kinase 4, Ubiquitination, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review